One-Year Results Longer-term studies assess how much progress was maintained, whether weight reduction continued, how metabolic markers changed, and how well participants tolerated treatment over time
For researchers in Canada who want to review the current option available through Great Northern Peptides, see the retatrutide page here
The Hair Loss Timeline: When It Starts, Peaks, and Stops Source: Dermatology literature on telogen effluvium + GLP-1 clinical trial adverse event data (STEP and SURMOUNT trials)
Safety depth A safe GLP-1 path includes a medical-history review, contraindication screening, medication-interaction review, and clear instructions for side effects
doi: 10.3389/fmicb.2023.1272754 522 SwansonKSGibsonGRHutkinsRReimerRAReidGVerbekeKet al
Patients can easily schedule appointments at their Brooklyn location